Literature DB >> 9525825

Leptomeningeal metastases: evaluation by gadolinium enhanced spinal magnetic resonance imaging.

J M Gomori1, N Heching, T Siegal.   

Abstract

BACKGROUND: Leptomeningeal metastases are common in patients with metastatic systemic cancer or certain primary brain tumors. They may be unsuspected clinically and may be missed by cerebrospinal fluid (CSF) cytology. We undertook a retrospective study of the diagnostic value of gadolinium enhanced spinal MR imaging in patients with known or at high risk for leptomeningeal metastases (LM).
MATERIAL AND METHODS: Ninety-six gadolinium enhanced MR examinations of the whole spine were performed in 61 patients (26 primary central nervous system tumors, 20 solid tumors and 15 lymphoproliferative neoplasms). All patients had detailed neurological evaluation and concomitant CSF examination.
RESULTS: Sixty-one MR's (62%) were positive, mostly in the lumbar spine. MR's were positive in 92% of patients with positive initial CSF cytology and in 60% of patients with negative CSF cytology. The MR examination was positive in 49% of those without clinical findings related to the spinal region. It showed disease beyond the symptomatic level in 42% of patients with spinal symptomatology. Multi-level spinal involvement was present in 57% of positive MR exams.
CONCLUSION: Enhanced spinal MR is sensitive for the detection of neoplastic spinal seeding. It detects LM in about 50% of high risk patients with negative initial CSF cytology or no spinal symptoms.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9525825     DOI: 10.1023/a:1005783507544

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  7 in total

1.  Leptomeningeal metastasis: a comparison of gadolinium-enhanced MR and contrast-enhanced CT of the brain.

Authors:  M C Chamberlain; A D Sandy; G A Press
Journal:  Neurology       Date:  1990-03       Impact factor: 9.910

2.  Leptomeningeal metastases: MR evaluation.

Authors:  D M Yousem; P M Patrone; R I Grossman
Journal:  J Comput Assist Tomogr       Date:  1990 Mar-Apr       Impact factor: 1.826

3.  Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis.

Authors:  R J Freilich; G Krol; L M DeAngelis
Journal:  Ann Neurol       Date:  1995-07       Impact factor: 10.422

4.  Neuroradiologic findings in leptomeningeal carcinomatosis: the value interest of gadolinium-enhanced MRI.

Authors:  G Rodesch; P Van Bogaert; N Mavroudakis; P M Parizel; J J Martin; C Segebarth; M Van Vyve; D Baleriaux; J Hildebrand
Journal:  Neuroradiology       Date:  1990       Impact factor: 2.804

5.  Leptomeningeal metastases: analysis of 31 patients with sustained off-therapy response following combined-modality therapy.

Authors:  T Siegal; A Lossos; M R Pfeffer
Journal:  Neurology       Date:  1994-08       Impact factor: 9.910

6.  Comparison of myelography with CT follow-up versus gadolinium MRI for subarachnoid metastatic disease in children.

Authors:  E D Kramer; S Rafto; R J Packer; R A Zimmerman
Journal:  Neurology       Date:  1991-01       Impact factor: 9.910

7.  Comparative spine imaging in leptomeningeal metastases.

Authors:  M C Chamberlain
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

  7 in total
  12 in total

Review 1.  Leukemia and the nervous system.

Authors:  Marc C Chamberlain
Journal:  Curr Oncol Rep       Date:  2005-01       Impact factor: 5.075

2.  Leptomeningeal carcinomatosis with involvement of the cerebellar hemispheres and the spinal cord as first manifestation of a metastasizing breast carcinoma.

Authors:  T C Sabou; P Kamusella; R Andresen
Journal:  Clin Neuroradiol       Date:  2013-08-04       Impact factor: 3.649

3.  Meningeal carcinomatosis in breast cancer: prognostic factors and outcome.

Authors:  Carla Rameri Alexandre Silva de Azevedo; Marcelo Rocha Sousa Cruz; Ludmilla Thomé Domingos Chinen; Stela Verzinhasse Peres; Marcos Aurélio Peterlevitz; Artur Eugênio de Azevedo Pereira; Marcello Ferretti Fanelli; Daniel Luiz Gimenes
Journal:  J Neurooncol       Date:  2011-01-14       Impact factor: 4.130

4.  Nonenhancing spinal subdural metastatic tumor.

Authors:  Zoran Rumboldt; Lara Lambert; Jasna Talan-Hranilovic; Domagoj Marjan; Tomislav Sajko
Journal:  AJNR Am J Neuroradiol       Date:  2005-10       Impact factor: 3.825

Review 5.  Leukemic and lymphomatous meningitis: incidence, prognosis and treatment.

Authors:  Marc C Chamberlain; Craig Nolan; Lauren E Abrey
Journal:  J Neurooncol       Date:  2005-10       Impact factor: 4.130

6.  The value of tandem CSF/MRI evaluation for predicting disseminated disease in childhood central nervous system neoplasms.

Authors:  Judy Pang; Anuradha Banerjee; Tarik Tihan
Journal:  J Neurooncol       Date:  2007-11-07       Impact factor: 4.130

7.  Leptomeningeal carcinomatosis from oesophageal cancer, presenting as meningitis.

Authors:  Mashrafi Ahmed; Tahmina Begum; Abdel Rahman Omer; Ishtiaque Amin Khan
Journal:  BMJ Case Rep       Date:  2016-01-06

8.  Confusion and altered behaviour? Cause.

Authors:  Ronstan Lobo; Isweri Pillay; Barry Kennedy; Michael Watts
Journal:  BMJ Case Rep       Date:  2013-01-21

Review 9.  Leptomeningeal metastases: rationale for systemic chemotherapy or what is the role of intra-CSF-chemotherapy?

Authors:  T Siegal
Journal:  J Neurooncol       Date:  1998 Jun-Jul       Impact factor: 4.130

Review 10.  Strategies for increasing drug delivery to the brain: focus on brain lymphoma.

Authors:  Tali Siegal; Ester Zylber-Katz
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 5.577

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.